Lincoln Capital’s Medtronic MDT Stock Holding History

Lincoln Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,111	Closed	-$234K	–	108
2022 Q1	$234K	Sell	2,111 -80	-4%	-$8.45K	0.05%	102
2021 Q4	$227K	Hold	2,191	–	–	0.06%	100
2021 Q3	$275K	Hold	2,191	–	–	0.07%	91
2021 Q2	$272K	Hold	2,191	–	–	0.08%	89
2021 Q1	$259K	Hold	2,191	–	–	0.08%	83
2020 Q4	$257K	Hold	2,191	–	–	0.08%	81
2020 Q3	$228K	Hold	2,191	–	–	0.08%	81
2020 Q2	$201K	Buy	+2,191	New	+$210K	0.08%	81
2020 Q1	–	Sell	-2,140	Closed	-$243K	–	76
2019 Q4	$243K	Hold	2,140	–	–	0.1%	76
2019 Q3	$232K	Hold	2,140	–	–	0.1%	73
2019 Q2	$208K	Buy	+2,140	New	+$195K	0.09%	75
2018 Q4	–	Sell	-2,140	Closed	-$211K	–	72
2018 Q3	$211K	Buy	+2,140	New	+$198K	0.1%	73
2016 Q4	–	Sell	-3,211	Closed	-$277K	–	66
2016 Q3	$277K	Hold	3,211	–	–	0.2%	48
2016 Q2	$279K	Sell	3,211 -50	-2%	-$4.04K	0.21%	47
2016 Q1	$245K	Sell	3,261 -50	-2%	-$3.77K	0.18%	52
2015 Q4	$255K	Hold	3,311	–	–	0.2%	47
2015 Q3	$222K	Sell	3,311 -30	-0.9%	-$2.21K	0.18%	50
2015 Q2	$248K	Sell	3,341 -160	-5%	-$12.2K	0.21%	47
2015 Q1	$273K	Buy	+3,501	New	+$265K	0.23%	43

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lincoln Capital's MDT Position: Q2 2022 in Review

Lincoln Capital sold out of Medtronic (MDT) in Q2 2022, closing a stake of 2,111 shares — an estimated $234K sold.

Lincoln Capital first reported a position in MDT in Q1 2015 and held it in 19 quarters. The position peaked at $279K in Q2 2016. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

Lincoln Capital reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
Lincoln Capital sold 2,111 Medtronic shares in Q2 2022, an estimated $234K.
Lincoln Capital first reported a position in Medtronic in Q1 2015 and held it in 19 quarters.
Lincoln Capital's Medtronic position peaked at $279K in Q2 2016.
2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Lincoln Capital's 13F filing for Q2 2022, filed 20 Jul 2022.